JP2022169627A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022169627A5 JP2022169627A5 JP2022127495A JP2022127495A JP2022169627A5 JP 2022169627 A5 JP2022169627 A5 JP 2022169627A5 JP 2022127495 A JP2022127495 A JP 2022127495A JP 2022127495 A JP2022127495 A JP 2022127495A JP 2022169627 A5 JP2022169627 A5 JP 2022169627A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- seq
- axillary
- underarm
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 10
- 108020004459 Small interfering RNA Proteins 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 4
- 239000004055 small Interfering RNA Substances 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 102100021501 ATP-binding cassette sub-family B member 5 Human genes 0.000 claims 2
- 102100037129 ATP-binding cassette sub-family C member 11 Human genes 0.000 claims 2
- 101000677872 Homo sapiens ATP-binding cassette sub-family B member 5 Proteins 0.000 claims 2
- 101001029057 Homo sapiens ATP-binding cassette sub-family C member 11 Proteins 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 210000004392 genitalia Anatomy 0.000 claims 2
- 230000004048 modification Effects 0.000 claims 2
- 238000012986 modification Methods 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 238000010521 absorption reaction Methods 0.000 claims 1
- 210000002210 apocrine cell Anatomy 0.000 claims 1
- 238000007385 chemical modification Methods 0.000 claims 1
- 210000000038 chest Anatomy 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 210000000115 thoracic cavity Anatomy 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662368896P | 2016-07-29 | 2016-07-29 | |
| US62/368,896 | 2016-07-29 | ||
| PCT/US2017/044731 WO2018023126A1 (en) | 2016-07-29 | 2017-07-31 | Methods of treating osmidrosis |
| JP2019526209A JP2019523302A (ja) | 2016-07-29 | 2017-07-31 | 腋臭を治療する方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019526209A Division JP2019523302A (ja) | 2016-07-29 | 2017-07-31 | 腋臭を治療する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022169627A JP2022169627A (ja) | 2022-11-09 |
| JP2022169627A5 true JP2022169627A5 (enExample) | 2023-04-24 |
Family
ID=61016798
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019526209A Pending JP2019523302A (ja) | 2016-07-29 | 2017-07-31 | 腋臭を治療する方法 |
| JP2022127495A Pending JP2022169627A (ja) | 2016-07-29 | 2022-08-10 | 腋臭を治療する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019526209A Pending JP2019523302A (ja) | 2016-07-29 | 2017-07-31 | 腋臭を治療する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US20210301289A1 (enExample) |
| EP (1) | EP3491129A4 (enExample) |
| JP (2) | JP2019523302A (enExample) |
| KR (1) | KR20190123256A (enExample) |
| WO (1) | WO2018023126A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019391791A1 (en) * | 2018-12-03 | 2021-06-03 | Eirion Therapeutics, Inc. | Improved delivery of large agents |
| CN110124042A (zh) * | 2019-05-28 | 2019-08-16 | 赵叶莲 | 不含铝的抑制腋臭的组合物 |
| EP4019048A4 (en) * | 2019-08-21 | 2023-10-04 | The University of Tokyo | ABCC11 INHIBITOR |
| WO2021257630A2 (en) * | 2020-06-15 | 2021-12-23 | Cutler Richelle | Drugs and methods for reducing body odor and sweat |
| WO2024104663A1 (en) | 2022-11-16 | 2024-05-23 | Unilever Ip Holdings B.V. | Method of reducing malodour |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7148342B2 (en) * | 2002-07-24 | 2006-12-12 | The Trustees Of The University Of Pennyslvania | Compositions and methods for sirna inhibition of angiogenesis |
| EP1747462A2 (en) * | 2004-04-27 | 2007-01-31 | Galapagos N.V. | Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| US20120150023A1 (en) * | 2007-08-06 | 2012-06-14 | Kaspar Roger L | Microneedle arrays for active agent delivery |
| WO2012103035A1 (en) * | 2011-01-24 | 2012-08-02 | Anterios, Inc. | Nanoparticle compositions |
| CA2844805A1 (en) * | 2011-08-16 | 2013-02-21 | Oncocyte Corporation | Methods and compositions for the treatment and diagnosis of breast cancer |
| WO2016094732A1 (en) * | 2014-12-10 | 2016-06-16 | Transderm, Inc. | METHODS OF TREATING PAIN AND/OR ITCH WITH SMALL MOLECULE INHIBITORS TARGETING AN mTOR PATHWAY |
-
2017
- 2017-07-31 KR KR1020197005466A patent/KR20190123256A/ko not_active Ceased
- 2017-07-31 WO PCT/US2017/044731 patent/WO2018023126A1/en not_active Ceased
- 2017-07-31 JP JP2019526209A patent/JP2019523302A/ja active Pending
- 2017-07-31 EP EP17835426.2A patent/EP3491129A4/en not_active Withdrawn
- 2017-07-31 US US16/321,583 patent/US20210301289A1/en not_active Abandoned
-
2022
- 2022-08-10 JP JP2022127495A patent/JP2022169627A/ja active Pending
-
2023
- 2023-04-06 US US18/131,509 patent/US20240167028A1/en not_active Abandoned
-
2024
- 2024-11-25 US US18/959,170 patent/US20250188461A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022169627A5 (enExample) | ||
| JP7095028B2 (ja) | 薬学的組成物及び方法 | |
| DK2694652T3 (en) | MEDICINE FOR LIVER REGENERATION AND FOR THE TREATMENT OF LIVER FAILURE | |
| JP2015523855A (ja) | Ａｐｏａ１及びａｂｃａ１発現を調節するための組成物及び方法 | |
| CN110934873B (zh) | 靶向组织微环境中衰老细胞的抗衰老药物d/s及其应用 | |
| US9914926B2 (en) | Fidgetin-like 2 as a target to enhance wound healing | |
| JP2015523853A (ja) | Ａｔｐ２ａ２発現を調節するための組成物及び方法 | |
| JP2015518710A (ja) | ヘモグロビン遺伝子ファミリー発現を調節するための組成物及び方法 | |
| JP7039470B2 (ja) | がんの治療において治療薬として使用するための、モノカルボン酸トランスポーター４（ｍｃｔ４）アンチセンスオリゴヌクレオチド（ａｓｏ）阻害剤 | |
| WO2023051822A1 (zh) | 用于治疗与pcsk9相关疾病的靶向寡核苷酸 | |
| JP2019523302A5 (enExample) | ||
| Lu et al. | Pachymic acid sensitizes gastric cancer cells to radiation therapy by upregulating bax through hypoxia | |
| JP2007501239A (ja) | 放射線治療と組み合わせたｖｅｇｆアンタゴニストの使用 | |
| Xiao et al. | An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage‐dependent mechanism | |
| US20160108431A1 (en) | Prevention and treatment of atrial fibrillation | |
| WO2021150756A1 (en) | Inhibitors of glutathione s-transferases (gsts) and nad(p)h:quinone oxidoreductase 1 (nqo1), pharmaceutical compositions, and uses in managing cancer | |
| CN110859960B (zh) | 靶向AMPK的抑制剂/siRNA与蛋白酶体抑制剂组合在制备抗肿瘤药物中的应用 | |
| CN115381953B (zh) | Zip1在抑制瑞芬太尼诱发的痛觉过敏中的应用 | |
| ES2374244B1 (es) | MicroRNA útil para el tratamiento de canalopatías arritmogénicas. | |
| WO2025130826A1 (en) | Compositions and methods for treating cancer | |
| CN102888403A (zh) | miRNA-539及其反义核苷酸的用途和其药物组合物 | |
| CN120738343A (zh) | 一种锁核酸在制备治疗肺高压药物中的应用 | |
| Subramaniam et al. | DIPG-38. VAL-083 IN COMBINATION WITH AZD1775 FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA | |
| Saito et al. | DDDR-03. DEVELOPMENT OF ANTI-TUMOR AROMA THERAPY FOR GLIOBLASTOMA WITH LEMONGRASS ESSENTIAL OIL | |
| Zhou et al. | DIPG-39. ONCOHISTONE H3. 3K27M-DRIVEN CREB5/ID1 AXIS DICTATES THE MALIGNANT CELL STATES OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) |